SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Velvette International Pharma Products Ltd (524528)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524528 NSE: Household & Personal Products | Small Cap | Velvette Intl. Phar Share Price

BSE Share Price
Not Listed

Velvette International Pharma Products Ltd (524528)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524528 NSE: Household & Personal Products | Small Cap | Velvette Intl. Phar Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹2 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-1.5
TTM Sales
₹0.9 Cr.
Book Value per Share
₹-9.4
P/E Ratio
0.00
Industry PE
47.7
Price to Book (P/B)
-0.33
Price to Sales (P/S)
1.66
EV/EBITDA
-20.19
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
-12.84%
Return on Assets (ROA)
-8.56%
Operating Profit Margin
-72.7%
Net Profit Margin
-82.3%
Gross Profit Margin
-70%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-82.03%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
32.17%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-9 Cr.
Equity
₹4.9 Cr.
Face Value
₹10
All Time Low / High
₹0.64 / 8.25

Velvette International Pharma Products stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
ROCE % 5.4%5.8%8.5%4.3%-98.7%-4.6%-12.8%-

Growth Parameters

Sales 856.15.345.10.91
Sales YoY Gr.--37.5%22.2%-13.7%-24.8%29%-82%-
Adj EPS -2.4-0.80.10-27-0.6-1.5-1.5
YoY Gr.-NANA-20%-67675%NANA-
BVPS (₹) 8.48.69.210.4-15.5-10.3-10.9-9.4
Adj Net
Profit
-0.9-0.300-10.1-0.3-0.8-1
Cash Flow from Ops. -0.1-0.3-0.7-0.2-0.2-0.30.1-
Debt/CF from Ops. -203-33.6-16.2-63-53.2-32.874.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-28.8%-44.2%-82%
Adj EPS NANA-437.7%NA
BVPSNA-205%-201.7%NA
Share Price - - - -

Key Financial Parameters

Mar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
Return on
Equity %
-14.2-4.70.30.3-930.87.116.815.1
Op. Profit
Mgn %
9.517.920.89.7-241.7-3.1-72.716.9
Net Profit
Mgn %
-11.1-5.80.30.3-254-5.6-82.3-82.5
Debt to
Equity
33.13.12.8-1.9-2.1-2-
Working Cap
Days
01,0367879569224482,5740
Cash Conv.
Cycle
0301478644544772880

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Sales8.025.016.125.283.975.120.92
Operating Expenses + 7.264.114.854.7713.575.281.59
Manufacturing Costs0.090.050.050.060.100.110.04
Material Costs3.902.352.722.801.911.890.45
Employee Cost 0.600.360.390.340.470.540.13
Other Costs 2.661.351.691.5811.102.740.97
Operating Profit 0.760.891.270.51-9.60-0.16-0.67
Operating Profit Margin (%) 9.5%17.9%20.8%9.7%-241.0%-3.1%-72.7%
Other Income + 0.080.020.040.240.070.040.07
Exceptional Items 0000000
Interest 1.571.031.140.480.430.040.04
Depreciation 0.160.180.150.140.120.130.11
Profit Before Tax -0.89-0.290.020.14-10.09-0.29-0.76
Tax 0000.02000
Profit After Tax -0.89-0.290.020.11-10.09-0.29-0.76
PAT Margin (%) -11.1%-5.8%0.4%2.2%-253.0%-5.6%-82.3%
Adjusted EPS (₹)-2.4-0.80.10.3-27.0-0.6-1.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Valuation of Velvette Intl. Phar - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05

Equity and Liabilities

Shareholders Fund + 6.2966.026.13-3.96-4.14-4.90
Share Capital 3.733.733.733.733.734.934.93
Reserves 2.552.262.292.39-7.69-9.08-9.83
Debt +9.469.8910.7010.6510.8110.8810.74
Long Term Debt9.469.8910.7010.6510.8110.8810.74
Short Term Debt0000000
Minority Interest0000000
Trade Payables5.242.071.431.561.391.681.70
Others Liabilities 0.090.120.040.151.330.910.84
Total Liabilities 21.0818.0818.1918.479.579.338.37

Fixed Assets

Net Fixed Assets +2.141.971.821.651.591.471.35
Gross Block3.543.543.543.503.563.723.72
Accumulated Depreciation1.391.571.721.851.972.252.36
CWIP 0000000
Investments 0.130.130.130.130.130.130.13
Inventories0.550.070.030.240.720.160.14
Trade Receivables10.6810.7111.0711.392.502.472.03
Cash Equivalents 0.170.250.190.260.160.110.11
Others Assets 7.414.964.944.804.484.994.61
Total Assets 21.0818.0818.1918.479.579.338.37

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Cash Flow From Operating Activity + -0.05-0.29-0.66-0.17-0.20-0.330.14
PBT -0.89-0.290.020.14-10.09-0.29-0.76
Adjustment 2.141.611.720.919.510.700.68
Changes in Working Capital 0.28-0.59-1.26-0.740.8-0.70.26
Tax Paid 0000000
Cash Flow From Investing Activity + -1.34-0.06-0.200.05-0.062.100
Capex -0-0-00.17-0.062.100
Net Investments 0000000
Others -1.33-0.06-0.20-0.110-00
Cash Flow From Financing Activity + 1.250.430.810.180.16-1.83-0.14
Net Proceeds from Shares 0000000
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 1.250.430.810.180.16-1.83-0.14
Net Cash Flow -0.130.08-0.060.07-0.10-0.060

Financial Ratio

PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Ratios
ROE (%)-28.48-9.20.663.1N/AN/AN/A
ROCE (%)5.415.768.514.28N/AN/AN/A
Asset Turnover Ratio0.380.260.340.290.280.540.1
PAT to CFO Conversion(x)N/AN/A-33-1.55N/AN/AN/A
Working Capital Days
Receivable Days486779.20649.40775.90638.10177.30893.20
Inventory Days25.1022.6039.6044.1031.4060.50
Payable Days490.20566.60234.70194.70280.40296.201,373.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Velvette International Pharma Products Ltd FAQs

The current trading price of Velvette Intl. Phar on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Velvette Intl. Phar stood at ₹1.53 Cr

The latest P/E ratio of Velvette Intl. Phar as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Velvette Intl. Phar as of 31-Dec-1969 is -0.33.

The 52-week high of Velvette Intl. Phar is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Velvette Intl. Phar is ₹0.92 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Velvette International Pharma Products Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: